Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2884 of 5804
-
Cialis and keytruda together against head and neck cancer: small trial shows promise?
Disease control CompletedThis study will examine the combination of pembrolizumab and tadalafil for safety and efficacy in advanced head and neck cancer.
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can early liver transplants save lives in alcoholic hepatitis? new study aims to find out
Knowledge-focused ENROLLING_BY_INVITATIONThe purpose of this study is to develop a clinical understanding of early liver transplantation (ELT) for patients with severe alcoholic hepatitis (SAH) and identify the public's opinion regarding this practice.
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Could a magnetic helmet boost brainpower in Parkinson's?
Symptom relief Recruiting nowThe purpose of this study is to examine safety, feasibility, and the behavioral and brain effects of a non-invasive treatment, repetitive transcranial magnetic stimulation (rTMS), for Veterans with Parkinson's disease or atypical parkinsonism and mild impairments in their thinkin…
Phase: PHASE1, PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
MitoQ trial targets MS fatigue – a new hope for tired patients?
Symptom relief CompletedThe purpose of this study is to determine whether MS patients who receive Oral mitoquinone (MitoQ) have less fatigue than those receiving a placebo. A comparison between patient's fatigue scored at baseline and fatigue scored 12 weeks after drug initiation will assess if MitoQ ha…
Phase: PHASE1, PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Experimental COM902 drug shows promise in early cancer trial
Disease control CompletedPhase 1 open label sequential dose escalation and cohort expansion study evaluating the safety, tolerability and preliminary antitumor activity of COM902 as monotherapy and in combination with COM701 in subjects with advanced malignancies.
Phase: PHASE1 • Sponsor: Compugen Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug combo shows promise for blood cancer patients
Disease control OngoingThe purpose of this study is to determine the safety, tolerability; and to define the maximum tolerated dose (MTD) and Recommended Phase 2 Dose (RP2D); and to evaluate the safety and tolerability of the ramp-up dosing schedule and at the RP2D of BGB-11417 monotherapy, and when gi…
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New MRI technique may spot brain tumor return vs. radiation scar
Diagnosis Recruiting nowThis trial uses magnetic resonance elastography (MRE) to estimate tissue stiffness (hardness or softness of the tissue) in tissue that is affected by radiation treatment (radiation necrosis) and tumor tissue that has come back (recurrent) after treatment in patients with gliomas.…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
New study tracks best ways to treat hemophilia a when standard therapy fails
Knowledge-focused Recruiting nowThis is a non-interventional, multicenter, observational, international study in male persons with haemophilia A who have developed inhibitors to any replacement coagulation factor VIII (FVIII) product. The purpose of the study is to capture different approaches in the management…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:08 UTC
-
Spinal cord injury study tests magnetic pulses to restore grip
Knowledge-focused TerminatedThe overall goals of this proposal are to examine the contribution of physiological pathways to the control of grasping behaviors after cervical SCI, and to maximize the recovery of grasping by using tailored non-invasive brain stimulation and acoustic startle protocols with moto…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
RNA clues may reveal stroke recovery secrets
Knowledge-focused Recruiting nowEVTRNA is to analyze the differentiated expression pattern of circular RNA (circRNA), long non-coding RNA (lncRNA) and micro-RNA (miRNA) by next-generation sequencing in acute ischemic stroke patients before and/or after endovascular treatment. The candidate circRNA/lncRNA/miRNA …
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Stroke rehab gets a game boost: can playing as a dolphin help heal?
Symptom relief CompletedThe investigators are investigating ways to incorporate new technologies that can enhance functional outcome after neurological insult into the patient recovery space. In order to accelerate the translation of these technologies to patient care spaces, the investigators need to i…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Brain surgery breakthrough? sedative may shield the brain!
Disease control CompletedBrain tumor surgery is commonly associated with different degrees of preoperative intracranial hypertension and surrounding tumor edema, elicited by tumor underlying pathophysiology. During craniotomy for brain tumor resection maintenance of hemodynamic stability and intracranial…
Phase: PHASE4 • Sponsor: Georgia Tsaousi • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
COVID lung damage: who gets scarred?
Knowledge-focused OngoingThe COVID-19 pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS CoV-2), an emerging coronavirus, which has already infected 192 million people with a case fatality rate close to 2%. About 5% of patients infected with SARS CoV-2 have a critical form wi…
Sponsor: Hôpital Européen Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
New drug combo shows promise for tough lung cancer
Disease control OngoingThis phase Ib trial studies the side effects and best dose of brigatinib and how well it works with bevacizumab in treating patients with ALK-rearranged non-small cell lung cancer that has spread to nearby tissues or lymph nodes (locally advanced) or other places in the body (met…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Epilepsy study aims to predict who will respond to treatment
Knowledge-focused CompletedBy carrying a careful, large-scale and ambitious prospective study of a cohort of participants with generalized epilepsy, the study team hopes to clarify the likelihood of response and remission in this type of epilepsy, and try to explore the underlying biological drivers of tre…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis study will evaluate the safety, tolerability, pharmacokinetics, and activity of XmAb24306 alone or in combination with a checkpoint inhibitor treatment in participants with locally advanced or metastatic solid tumors.
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Simple checklist could help GPs spot baby hip issues earlier
Diagnosis OngoingDevelopmental dysplasia of the hip (DDH) is one of the most common inborn diseases. Early diagnosis of this condition is very important and it can be harmful both to miss DDH and label normal infants as having DDH. Why DDH can be missed or labelled to normal children is not well …
Phase: NA • Sponsor: Great Ormond Street Hospital for Children NHS Foundation Trust • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Cancer survivors find hope in Peer-Led Self-Management program
Symptom relief OngoingThe investigators aim to evaluate a peer-to-peer patient self-management program targeting symptoms of anxiety and depression in a randomized trial. A total of 234 cancer patients recently having completed primary treatment with curative intent in central Region Denmark will be i…
Phase: NA • Sponsor: University of Aarhus • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
New robotic glove aims to restore hand movement after stroke
Symptom relief Recruiting nowThis study is designed to further develop and test the hardware and software components of the MyHand device based on user feedback and results from our pilot study. The goal is to refine the device so that is more effective and easier for stroke patients to use to increase their…
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Soothing sounds may shield seniors from ICU brain fog
Symptom relief CompletedCritically ill older adults admitted to the intensive care unit (ICU) are at a higher risk to develop delirium, which predisposes them to longer lengths of ICU and hospital stay, increased in-patient mortality, and higher risk of new acquired cognitive impairment and dementia. Mu…
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC